Table 3.
Training set (n = 383) | Validation set (n = 191) | |||||
---|---|---|---|---|---|---|
AUC | 95% CI | P value | AUC | 95% CI | P value | |
Child–Pugh | 0.662 | 0.580–0.745 | <0.001 | 0.669 | 0.555–0.783 | 0.006 |
MELD | 0.595 | 0.516–0.674 | =0.020 | 0.621 | 0.499–0.742 | 0.048 |
ALBI | 0.673 | 0.597–0.748 | <0.001 | 0.715 | 0.606–0.825 | <0.001 |
APRI | 0.707 | 0.638–0.777 | <0.001 | 0.604 | 0.487–0.720 | 0.089 |
PALBI | 0.731 | 0.653–0.808 | <0.001 | 0.669 | 0.558–0.782 | 0.006 |
FIB-4 | 0.758 | 0.692–0.824 | <0.001 | 0.716 | 0.623–0.809 | <0.001 |
Nomogram | 0.832 | 0.777–0.886 | <0.001 | 0.803 | 0.723–0.883 | <0.001 |
Abbreviations: MELD, model for end-stage liver disease; ALBI, albumin-bilirubin; APRI, aspartate aminotransferase to platelet ratio index; PALBI, platelet-albumin-bilirubin; FIB-4, fibrosis-4 index.